Clinical trial

Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone…

NCT00343616 · ETOP IBCSG Partners Foundation, Other · Completed

Key facts

NCT number NCT00343616
Title Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98
Official title Investigating Cognitive Function for Patients Participating in the BIG Trial 1-98 in Select Centers
Lead sponsor ETOP IBCSG Partners Foundation, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its Treatment
Intervention type Procedure
Interventions cognitive assessment, fatigue assessment and management, psychologic distress, quality-of-life assessment
Enrollment 135
Start date Apr 1, 2005
Primary completion May 1, 2008
Completion May 1, 2009
First posted Jun 23, 2006
Last update posted Jul 27, 2012
Countries Australia, Belgium, Italy, New Zealand, Switzerland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies